YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Hot Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorecta...

Eric Van Cutsem ; Claus-Henning Köhne ; Erika Hitre ; Jerzy Zaluski ; Chung-R... NEW ENGLAND JOURNAL OF MEDICINE, Vol.360(14) : 1408-1417, 2009

PDF Read more

This table browses all dspace content
Issue Date	Title	Journal Title
2023	Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors	ADVANCES IN THERAPY
2023	Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis	AMERICAN JOURNAL OF NEPHROLOGY
2023	Cre-loxP System-Based Mouse Model for Investigating Graves' Disease and Associated Orbitopathy	THYROID
2023	Endoscopic (ERCP and EUS) revision of occluded biliary stents	International Journal of Gastrointestinal Intervention
2023	Potent P2Y12 Inhibitor Monotherapy for Acute Coronary Syndrome	CIRCULATION JOURNAL
2023	Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
2023	Early Circulating Tumor DNA Dynamics and Efficacy of Lorlatinib in Patients With Treatment-Naive, Advanced, ALK-Positive NSCLC	JOURNAL OF THORACIC ONCOLOGY
2023	Impact of Low Skeletal Muscle Mass on Long-Term Outcomes in Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization: A Retrospective Multi-Center Study	CANCERS
2023	ADSC secretome constrains NK cell activity by attenuating IL-2-mediated JAK-STAT and AKT signaling pathway via upregulation of CIS and DUSP4	STEM CELL RESEARCH & THERAPY
2023	Early Aortic Valve Replacement in Symptomatic Normal-Flow, Low-Gradient Severe Aortic Stenosis: A Propensity Score-Matched Retrospective Cohort Study	KOREAN CIRCULATION JOURNAL
2023	Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data	TRANSLATIONAL LUNG CANCER RESEARCH
2023	Preparation and characterization of lysozyme loaded liposomal dry powder inhalation using non-ionic surfactants	INTERNATIONAL JOURNAL OF PHARMACEUTICS
2023	Efficacy of Percutaneous Coronary Intervention With Synergy Stents in Patients Aged ≥75 Years: 1-Year Clinical Outcomes from the Synergy Elderly Registry	AMERICAN JOURNAL OF CARDIOLOGY
2023	Relation of Gender to Atherosclerotic Plaque Characteristics by Differing Angiographic Stenosis Severity	AMERICAN JOURNAL OF CARDIOLOGY
2023	Low Skeletal Muscle Mass and Clinical Outcomes in Chronic Obstructive Pulmonary Disease	TUBERCULOSIS AND RESPIRATORY DISEASES
2023	ARID1A Mutation from Targeted NGS Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer	CANCER RESEARCH AND TREATMENT
2023	Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study	CANCER RESEARCH AND TREATMENT
2023	Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial	ECLINICALMEDICINE
2023	Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study	MOLECULAR CANCER THERAPEUTICS
2023	YAP1 Expression in HR+HER2- Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation	CANCERS